Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Mitomycin-C-Kyowa
Active Ingredient: Mitomycin 10mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Company
Manufacturer: Kyowa Hakko Kogyo Co Limited, Chiyoda-Ku, Tokyo, Japan
Note: This consent is valid for two years from 6 March 2005.
Product: Mitomycin-C-Kyowa
Active Ingredient: Mitomycin 2mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Company
Manufacturer: Kyowa Hakko Kogyo Co Limited, Chiyoda-Ku, Tokyo, Japan
Note: This consent is valid for two years from 6 March 2005.
Product: Mitomycin-C-Kyowa
Active Ingredient: Mitomycin 20mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Company
Manufacturer: Kyowa Hakko Kogyo Co Limited, Chiyoda-Ku, Tokyo, Japan
Note: This consent is valid for two years from 6 March 2005.
Product: Rescriptor
Active Ingredient: Delavirdine mesylate 100mg equivalent to 82.6mg delavirdine base
Dosage Form: Film-coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico
Note: This consent is valid for two years from 1 March 2005.
Dated this 2nd day of March 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).